Evidence, including systematic reviews, about treatment of opioid dependence and management of opioid overdose will be presented to the GDG. GDG members will contribute to the review of systematic reviews, evidence summaries, technical updates, and will propose recommendations. To address the issue, WHO has published guidelines for the psychosocially assisted pharmacological treatment of opioid dependence (2009) and community management of opioid overdose (2014). Drug, any chemical substance that affects the functioning of living things and the organisms (such as bacteria, fungi, and viruses) that infect them.
FRIDAY, Aug. 15, 2025 — Nearly half of U.S. adults should receive earlier treatment for high blood pressure, including lifestyle changes and medications,… WEDNESDAY, Aug. 20, 2025 — For the first time in 30 years, the American Academy of Pediatrics (AAP) has issued vaccine recommendations that differ… This second review of the world medicines situation (first published in 1988 as The WorldDrug Situation) presents the available evidence on global production,… The Guideline Development Group (GDG) is composed of members from all WHO regions, serving in their individual capacities rather than as representatives of affiliated organizations. GDG members were selected by WHO technical staff based on their technical expertise, their role as end-users (e.g., programme managers and healthcare providers), and their representation of affected communities.
Over 3 million annual deaths due to alcohol and drug use, majority among men
Today there are thousands of drugs on the market able to prevent, treat and lessen the impact of ailments that would have been fatal just a few generations ago. At the same time, antimicrobial resistance is challenging the effectiveness of many commonly used medicines in one of the most concerning threats to global health today. It presents a range of perspectives on how current challenges impact the manufacture, prescribing and access of medicines throughout the world and introduces newly-released guidance documents.
Receptors
In the choice of treatment, WHO recommends OAMT to be used for most patients as the intervention with strongest evidence of effectiveness for variety of outcomes. These include reduction in non-medical opioid use, mortality and morbidity (including due to opioid overdose, HIV and viral hepatitis), lowering risk of crime and incarceration, better retention in treatment, quality of life and overall wellbeing. In the guidelines on community management of opioid overdose, WHO recommends that people who are likely to witness an opioid overdose, including people who use opioids, and their family and friends should be given access to naloxone and training in its use so that they can respond to opioid overdose in an emergency. Target 3.5 of UN Sustainable Development Goal 3 sets out a commitment by governments to strengthen the prevention and treatment of substance abuse. It is crucial that people with opioid dependence and those at risk of opioid overdose have access to prevention, harm reduction, treatment, and care, which are of good quality, affordable, ethical and evidence based.
Seniors With Certain Cardiovascular Diseases Saw Life’s Essential 8 Scores Decline 2013 to 2018
- Differences in efficacy determine whether a drug that binds to a receptor is classified as an agonist or as an antagonist.
- A drug whose efficacy and affinity are sufficient for it to be able to bind to a receptor and affect cell function is an agonist.
- The publication was invited by resolution 58/5 of the Commission on Narcotic Drugs entitled “Supporting the collaboration of public health and justice…
- Since then there have been incredible advances in drugs for a wide range of health concerns including disease, mental health and other conditions.
- To ensure transparency and inclusivity, WHO invites members of the public and interested organizations to review the biographies of the GDG members and provide feedback.
- WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual…
Stigma, discrimination and misconceptions about drug rehab for pregnant women specialized prenatal treatment the efficacy of treatment contribute to these critical gaps in treatment provision, as well as the continued low prioritization of substance use disorders by health and development agencies. Receptors for many hormones and neurotransmitters have been isolated and biochemically characterized. All these receptors are proteins, and most are incorporated into the cell membrane in such a way that the binding region faces the exterior of the cell.
Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under international control. Building on the value of the BPPL as a global tool, tailoring the list to country and regional contexts can account for regional variations in pathogen distribution and the AMR burden. For example, antibiotic-resistant Mycoplasma genitalium, which is not included in the list, is an increasing concern in some parts of the world. Cannabis is globally the most commonly used psychoactive substance under international control. Effective treatment options for substance use disorders exist, but treatment coverage remains incredibly low. The proportion of people in contact with substance use treatment services ranged from less than 1% to no more than 35% in 2019, in countries providing this data.
Good Policy and Practice in Health Education: Education sector responses to the use of alcohol, tobacco…
Its power and versatility derive from the fact that the human body relies extensively on chemical communication systems to achieve integrated function between billions of separate cells. The body is therefore highly susceptible to the calculated chemical subversion of parts of this communication network that occurs when drugs are administered. The price of medicine remains the largest impediment toaccess and the economic impact of pharmaceuticals is substantial. They are thelargest public expenditure on health after personal costs in many low-incomecountries, and the expense is a major cause of household impoverishment anddebt. Public expenditure ranges widely between nations, from under 20% of totalhealthcare costs in high-income countries to up to 66% in low-income countries. With the ongoing emergence of more harmful substances, including clandestinely manufactured synthetic opioids with no medical use such as fentanyl and nitazenes, Member States expressed interest in more scientific reviews of these substances by WHO in the coming period.
- High priority pathogens, such as Salmonella and Shigella, are of particularly high burden in low- and middle-income countries, along with Pseudomonas aeruginosa and Staphylococcus aureus, which pose significant challenges in healthcare settings.
- In resolution S-30/1, the General Assembly adopted the outcome document of the special session on the world drug problem entitled “Our joint commitment to effectively addressing and countering the world drug problem”.
- In April 2016, the thirtieth Special Session of the UN General Assembly (UNGASS) reviewed the progress in the implementation of the 2009 Political Declaration and Plan of Action on International Cooperation Towards an Integrated and Balanced Strategy to Counter the World Drug Problem and assessed the achievements and challenges.
- Above-mentioned decisions were announced at the 68th regular session of the Commission on Narcotic Drugs, taking place in Vienna, Austria, on March 2025.
- The critical priority pathogens, such as gram-negative bacteria resistant to last-resort antibiotics, and Mycobacterium tuberculosis resistant to the antibiotic rifampicin, present major global threats due to their high burden, and ability to resist treatment and spread resistance to other bacteria.
- Since 1977, WHO has maintained a list of essentialmedicines as a means to promote health equity around the world.
Receptor activation briefly opens the transmembrane ion channel, and the resulting flow of ions across the membrane causes a change in the transmembrane potential of the cell that leads to the initiation or inhibition of electrical impulses. Examples include the receptors for acetylcholine and for other fast excitatory or inhibitory transmitter substances in the nervous system, such as glutamate and gamma-aminobutyric acid (GABA). Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection moving from critical to high priority in BPPL 2024 mirrors recent reports of decreases in global resistance. Despite this transition, investment in R&D and other prevention and control strategies for CRPA remains important, given its significant burden in some regions. Medium priority pathogens include Group A and B Streptococci (both new to the 2024 list), Streptococcus pneumoniae, and Haemophilus influenzae, which present a high disease burden.
This feedback helps WHO develop high-quality guidelines that reflect diverse perspectives and respond to the needs of communities worldwide. To ensure transparency and inclusivity, WHO invites members of the public and interested organizations to review the biographies of the GDG members and provide feedback. Manuals for the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and the ASSIST-linked brief interventionsThe ASSIST package, which…
Global status report on alcohol and health and treatment of substance use disorders
The Global status report on alcohol and health and treatment of substance use disorders presents a comprehensive overview of alcohol consumption, alcohol-related… Many receptor-mediated events show the phenomenon of desensitization, which means that continued or repeated administration of a drug produces a progressively smaller effect. Among the complex mechanisms involved are conversion of the receptors to a refractory (unresponsive) state in the presence of an agonist, so that activation cannot occur, or the removal of receptors from the cell membrane (down-regulation) after prolonged exposure to an agonist. Desensitization is a reversible process, although it can take hours or days for receptors to recover after down-regulation. The converse process (up-regulation) occurs in some instances when receptor antagonists are administered. These adaptive responses are undoubtedly important when drugs are given over a period of time, and they may account partly for the phenomenon of tolerance (an increase in the dose needed to produce a given effect) that occurs in the therapeutic use of some drugs.
Rates of current drinking were highest among 15–19-year-olds in the European region (45.9%) followed by the Americas (43.9%).
A drug with the affinity to bind to a receptor but without the efficacy to elicit a response is an antagonist. Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Millennium Development Goal 8E aims for affordable access to essential medicines.Essential medicines, as defined by WHO, are those that “satisfy…
Community management of opioid overdose
These pathogens require increased attention, especially in vulnerable populations including paediatric and elderly populations, particularly in resource-limited settings. High priority pathogens, such as Salmonella and Shigella, are of particularly high burden in low- and middle-income countries, along with Pseudomonas aeruginosa and Staphylococcus aureus, which pose significant challenges in healthcare settings. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to medicines, making people sicker and increasing the risk of disease spread, illness and deaths. The updated BPPL incorporates new evidence and expert insights to guide research and development (R&D) for new antibiotics and promote international coordination to foster innovation. Most of the 145 countries that reported data did not have a specific budget line or data on governmental expenditures for treatment of substance use disorders.